Elanco Animal Health (ELAN) Cash & Equivalents (2017 - 2026)
Elanco Animal Health (ELAN) posted Cash & Equivalents of $428.0 million for Q1 2026, down 21.47% sequentially from $545.0 million in Q4 2025, and down 12.11% YoY from $487.0 million in Q1 2025.
Elanco Animal Health (ELAN) Cash & Equivalents (2017 - 2026) Analysis & Trends
Elanco Animal Health has reported Cash & Equivalents for 10 years, with the latest figure at $428.0 million in Q1 2026.
- Quarterly Cash & Equivalents fell 12.11% year-over-year to $428.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $428.0 million (down 12.11% YoY) and the FY2025 annual result came in at $545.0 million, up 16.45% from the prior year.
- Cash & Equivalents retreated to $428.0 million in Q1 2026 per ELAN's latest filing, from $545.0 million in the prior quarter.
- Over five years, Cash & Equivalents peaked at $545.0 million in Q4 2025 and troughed at $318.0 million in Q1 2023.
- A 5-year average of $428.4 million and a median of $428.0 million in 2026 frame the typical range for Cash & Equivalents.
- The sharpest annual moves came in 2022 and 2025: Cash & Equivalents slumped 45.92% in 2022, then jumped 41.16% in 2025.
- Over 5 years, Cash & Equivalents stood at $345.0 million in 2022, then advanced by 2.03% to $352.0 million in 2023, then surged by 32.95% to $468.0 million in 2024, then rose by 16.45% to $545.0 million in 2025, then decreased by 21.47% to $428.0 million in 2026.
- According to Business Quant data, Cash & Equivalents over the past three periods registered $428.0 million, $545.0 million, and $505.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.81 Bn | 42.84 Bn | - | 1.11 Bn |
| 2 | Teva Pharmaceutical Industries | 43.29 Bn | 39.63 Bn | 2.15 Bn | 3.66 Bn |
| 3 | Zoetis | 31.59 Bn | 29.91 Bn | 1.05 Bn | 1.48 Bn |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.88 Bn | 5.10 Bn | 2.89 Bn |
| 5 | United Therapeutics | 22.24 Bn | 19.58 Bn | 683.80 Mn | 1.80 Bn |
| 6 | Viatris | 18.79 Bn | 17.91 Bn | 1.46 Bn | 886.50 Mn |
| 7 | Neurocrine Biosciences | 15.71 Bn | 15.32 Bn | 935.80 Mn | 332.40 Mn |
| 8 | Elanco Animal Health | 12.09 Bn | 11.56 Bn | 798.00 Mn | 530.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | 164.00 Mn |
| 10 | Alkermes | 8.19 Bn | 7.53 Bn | 397.90 Mn | 511.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 530.00 Mn |
| Mar 31, 2026 | 428.00 Mn |
| Dec 31, 2025 | 545.00 Mn |
| Sep 30, 2025 | 505.00 Mn |
| Jun 30, 2025 | 539.00 Mn |
| Mar 31, 2025 | 487.00 Mn |
| Dec 31, 2024 | 468.00 Mn |
| Sep 30, 2024 | 490.00 Mn |
| Jun 30, 2024 | 416.00 Mn |
| Mar 31, 2024 | 345.00 Mn |
| Dec 31, 2023 | 352.00 Mn |
| Sep 30, 2023 | 369.00 Mn |
| Jun 30, 2023 | 367.00 Mn |
| Mar 31, 2023 | 318.00 Mn |
| Dec 31, 2022 | 345.00 Mn |
| Sep 30, 2022 | 460.00 Mn |
| Jun 30, 2022 | 507.00 Mn |
| Mar 31, 2022 | 342.00 Mn |
| Dec 31, 2021 | 638.00 Mn |
| Sep 30, 2021 | 453.00 Mn |